• Perphenazine: Dopamine D2 Antagonist for Translational Resea

  2026-05-20

  Perphenazine stands at the intersection of neuropharmacology and immunology, enabling robust experimental designs for both cell death induction and host-directed antibacterial assays. This article delivers actionable guidance for optimizing workflows, troubleshooting common pitfalls, and leveraging cutting-edge reference findings to maximize the value of APExBIO’s Perphenazine.

• Perphenazine: Next-Gen Dopamine D2 Antagonist for Translatio

  2026-05-20

  Explore how Perphenazine, a multi-target dopamine D2 receptor antagonist, is redefining translational research by bridging neuropharmacology, host-directed antibacterial strategies, and advanced mechanistic workflows. This thought-leadership piece unpacks its receptor pharmacology, mitochondria-mediated cell death, and emerging immunomodulatory applications, offering protocol guidance and strategic perspectives for researchers aiming to translate bench insights to clinical innovation.

• EdU Imaging Kits (Cy5): Precision Tools for Endothelial Hype

  2026-05-19

  Explore how EdU Imaging Kits (Cy5) empower advanced studies of endothelial cell proliferation and vascular remodeling. This article reveals unique mechanistic insights and protocol guidance, making it a must-read for researchers seeking high-sensitivity S-phase detection.

• Dimethyloxalylglycine (DMOG): Workflow Guidance for Hypoxia

  2026-05-19

  Dimethyloxalylglycine (DMOG) is a cell-permeable inhibitor used to stabilize hypoxia-inducible factor (HIF) by blocking prolyl-4-hydroxylase domain enzymes, enabling controlled simulation of hypoxic signaling in research. Its use is recommended for in vitro and in vivo models focused on oxygen sensing, hypoxia pathways, and inflammation—not for diagnostic or medical applications.

• Toremifene Citrate: Applied Workflows in Breast Cancer Resea

  2026-05-18

  Toremifene Citrate sets the gold standard for modeling estrogen receptor signaling and advancing hormone receptor modulation studies. This guide demystifies optimal experimental setups, advanced assay applications, and troubleshooting strategies that leverage APExBIO’s rigorously characterized oral SERM for robust, translational breast cancer research.

• Reliable Excitotoxicity Models with NMDA (N-Methyl-D-asparti

  2026-05-18

  NMDA (N-Methyl-D-aspartic acid), especially as supplied in SKU B1624, is a gold-standard NMDA receptor agonist for building robust excitotoxicity and oxidative stress models in neuroscience research. This article explores real lab scenarios, evidence-driven protocol advice, and practical guidance for maximizing reproducibility and assay sensitivity using NMDA (N-Methyl-D-aspartic acid).

• Ceftolozane Sulfate: Optimizing Antibacterial Assays and PK/

  2026-05-17

  Ceftolozane sulfate empowers researchers to model and tackle resistant gram-negative infections, offering superior stability and potent activity against Pseudomonas aeruginosa. This article delivers actionable protocols, troubleshooting insights, and comparative context to accelerate translational anti-infective research.

• Cerium Oxide-Based Nanoplatforms Target Neuropathic Pain Mec

  2026-05-16

  Tian et al. introduce a multifunctional, magnetically targeted cerium oxide nanoplatform for neuropathic pain. By combining antioxidant, anti-inflammatory, and drug delivery functions, this system achieved significant pain relief and modulation of pathological pathways in a mouse model, offering a promising strategy for challenging pain conditions.

• Perphenazine: Dopamine D2 Receptor Antagonist in Research Wo

  2026-05-15

  APExBIO’s Perphenazine enables rigorous, multi-domain research from neuropharmacology to host-directed antibacterial studies. Explore advanced protocol design, performance insights, and troubleshooting strategies based on the latest mechanistic evidence.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-05-15

  Wang et al. reveal a novel METTL16-SENP3-LTF signaling axis that confers ferroptosis resistance and promotes tumorigenesis in hepatocellular carcinoma. This work delineates mechanistic links between m6A RNA modification and iron metabolism, providing a foundation for targeted strategies to sensitize HCC cells to ferroptosis.

• Ruxolitinib Phosphate (INCB018424): Applied JAK/STAT Modulat

  2026-05-14

  Ruxolitinib phosphate (INCB018424) sets a new standard for selective JAK1/JAK2 inhibition in both inflammation and oncology research. This article translates recent mechanistic breakthroughs into actionable protocols, optimizing workflows for cytokine signaling inhibition and advanced disease modeling.

• Reversine: Protocols and Best Practices for Aurora Kinase In

  2026-05-14

  Reversine is a small molecule Aurora kinase inhibitor designed for precise perturbation of mitotic regulation in cancer and cell cycle research. It is best applied in workflows requiring robust, reproducible inhibition of Aurora kinases A, B, and C, but should not be used for diagnostic or medical applications. Researchers must adhere to solubility and storage guidelines to ensure experimental reliability.

• Cy5-UTP for RNA Labeling: Enhanced In Vitro Transcription Wo

  2026-05-13

  Cy5-UTP (Cyanine 5-uridine triphosphate) transforms RNA probe synthesis by enabling direct, high-sensitivity fluorescent labeling for advanced molecular biology applications. This article details optimized experimental workflows, troubleshooting tips, and novel use-cases inspired by recent discoveries in mitotic regulation, firmly positioning APExBIO’s Cy5-UTP as a go-to reagent for in vitro transcription RNA labeling.

• Phenothiazines Boost Macrophage Antibacterial Action via ROS

  2026-05-13

  This study demonstrates that phenothiazines, including Perphenazine, enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) production and autophagy. These findings suggest host-directed therapies targeting innate immune mechanisms may offer promising alternatives in combating antibiotic-resistant intracellular bacterial infections.

• Naftifine HCl: Mechanistic Leverage for Translational Antifu

  2026-05-12

  This thought-leadership article explores Naftifine HCl as a model allylamine antifungal agent, focusing on its mechanistic role in ergosterol biosynthesis inhibition and its translational potential. Integrating recent cell signaling insights and referencing the WNT5a/GSK3/β-catenin axis in muscle biology, the article offers advanced strategic guidance for researchers seeking to bridge molecular antifungal mechanisms with broader cell fate modulation. Distinct from standard product pages, it provides protocol parameters, competitive context, and a visionary outlook grounded in current evidence.

308 records 8/21 page Previous Next First page 上5页 678910 下5页 Last page